Genomill appoints former foundation medicine executive and plans to present unmatched data at PMWC
Seminal presentation of first analytical validation data scheduled for june 30
<font color="#4B9CD2"> Genomeweb: </font> Genomill Health Positioning Geno1 Technology to Improve Liquid Biopsy Sequencing
NEW YORK – After closing an investment round last month for an undisclosed sum, Finnish firm Genomill Health is aiming to broaden adoption of its Geno1 technology, a barcoding-based method that it believes can enhance sequencing accuracy and lower costs and turnaround time for applications with high sensitivity and efficiency demands like liquid biopsy. The […]
Genomill Health closes investment round to expand beta-testing with liquid biopsy players
Genomill Health closes a financing round led by a deep tech VC Voima Ventures to expand its novel and disruptive technology, focusing on efficient use of NGS (next generation sequencing) in liquid biopsies for cancer diagnostics.